ECL
Get informed when a big investor buys or sells
+ FollowApril 28, 2026 - AI Summary
Overvalued by 32.2% based on the discounted cash flow analysis.
| Market cap | $75.74 Billion |
|---|---|
| Enterprise Value | $84.45 Billion |
| Dividend Yield | $2.92 (1.06%) |
| Earnings per Share | $7.33 |
| Beta | 0.91 |
| Outstanding Shares | 282,000,000 |
| P/E Ratio | 36.17 |
|---|---|
| PEG | 483.7 |
| Price to Sales | 4.64 |
| Price to Book Ratio | 7.7 |
| Enterprise Value to Revenue | 5.13 |
| Enterprise Value to EBIT | 30 |
| Enterprise Value to Net Income | 40 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.92 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2151▼ 41.14% |
|---|---|
| Total Calls | 755,900▲ 264.68% |
| Total Puts | 162,600▲ 25.22% |
Holdings and activity of institutional investors.
| Ownership % | 78.42%▼ 2.32% |
|---|---|
| Total Invested | $58.85B▼ 2.83% |
| Investors Holding | 1,717▲ 20.00% |
No data
This committee directly assists in crafting and analyzing tax legislation, providing crucial 'revenue estimates' that shape tax policy. Its work directly influences corporate tax burdens and investment incentives, fundamentally impacting Ecolab's financial structure.
This powerful committee controls taxation and trade. Its decisions on corporate tax policy, tariffs, and international trade agreements have a direct and significant impact on Ecolab's profitability, supply chain costs, and global competitiveness.
This committee regulates the FDA, which is highly relevant to Ecolab's food safety and healthcare infection prevention products. Labor laws also directly impact Ecolab's operational costs and workforce management.
This committee regulates the EPA, which has direct oversight over chemical manufacturing, use, and disposal, as well as water quality standards—all central to Ecolab's chemical products and water treatment solutions.